Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,237
datasets available to search
ShareScore release 0.9.0
Dataset results
1,237 results for “treatment outcome”
Data from: Usefulness of fecal calprotectin for the early prediction of short-term outcomes of remission-induction treatments in ulcerative colitis in comparison with two-item patient-reported outcome
Open the record for dataset details and reuse information.
Data from: An investigation of sepsis surveillance and emergency treatment on patient mortality outcomes: an observational cohort study
Open the record for dataset details and reuse information.
Evaluation of assisted reproductive technology treatment outcomes based on stimulation dosages and anti-mullerian hormone levels
Open the record for dataset details and reuse information.
Data from: Oncological and surgical outcome after treatment of pelvic sarcomas
Background and Objectives. Treatment of pelvic tumors remains challenging due to complex anatomy, poor oncological outcome and high complication rates. We sought to investigate the long-term oncological and surgical outcome of these patients. Methods. Between 1980 and 2012, 147 patients underwent surgical treatment for pelvic sarcoma. Histological diagnosis was Chondrosarcoma in 54, Ewing's Sarcoma/PNET in 37, Osterosarcoma in 32 and others in 24 patients. Statistical analysis for the evaluation of oncological and surgical outcome was performed by applying Cox proportional hazards regression and Fine-Gray regression models for competing risk (CR) endpoints. Results. The estimated overall survival (OS) to death was 80%, 45% and 37% at 1, 5 and 10 years, respectively. Univariate analyses revealed a statistically significant unadjusted influence of age age (p=0.038; HR=1.01), margin (p=0.043; HR=0.51) and grade (p=0.001; HR=2.27) on OS. Considering the multivariable model, grade (p=0.005; HR=3.04) and tumor volume (p=0.014; HR=1.18) presented themselves as independent prognostic factors on OS. CR analysis showed a cumulative incidence for major complication of 31% at 5 years. Endoprosthetic reconstruction had a higher risk for experiencing a major complication (p<0.0001) and infection (p=0.001). Conclusions. Pelvic resections are still associated with a high incidence of complications. Patients with pelvic reconstruction and high volume tumors are especially at risk. Consequently, a cautious decision-making process is necessary when indicating pelvic reconstruction, although a restrictive approach to pelvic reconstruction is not necessarily reasonable when the other option is major amputation.
PERIANAL CROHN'S DISEASE: A COMPREHENSIVE REVIEW OF DIAGNOSIS, TREATMENT, AND OUTCOMES
Open the record for dataset details and reuse information.
Raw Data for the article: Donor Simvastatin Treatment Is Safe and Might Improve Outcomes After Liver Transplantation: A Randomized Clinical Trial
<p><strong>Background: </strong>The current curative approaches for ischemia/reperfusion injury on liver transplantation are still under debate for their safety and efficacy in patients with end-stage liver disease. We present the SIMVA statin donor treatment before Liver Transplants study.</p> <p><strong>Methods: </strong>SIMVA statin donor treatment before Liver Transplants is a monocentric, double-blind, randomized, prospective tial aiming to compare the safety and efficacy of preoperative brain-dead donors' treatment with the intragastric administration of 80 mg of simvastatin on liver transplant recipient outcomes in a real-life setting. Primary aim was incidence of patient and graft survival at 90 and 180 d posttransplant; secondary end-points were severe complications.</p> <p><strong>Results: </strong>The trial enrolled 58 adult patients (18-65 y old). The minimum follow-up was 6 mo. No patient or graft was lost at 90 or 180 d in the experimental group (n = 28), whereas patient/graft survival were 93.1% ( P = 0.016) and 89.66% ( P = 0.080) at 90 d and 86.21% ( P = 0.041) and 86.2% ( P = 0.041) at 180 d in the control group (n = 29). The percentage of patients with severe complications (Clavien-Dindo ≥IIIb) was higher in the control group, 55.2% versus 25.0% in the experimental group ( P = 0.0307). The only significant difference in liver tests was a significantly higher gamma-glutamyl transferase and alkaline phosphatase at 15 d ( P = 0.017), ( P = 0.015) in the simvastatin group.</p> <p><strong>Conclusions: </strong>Donor simvastatin treatment is safe, and may significantly improve early graft and patient survival after liver transplantation, although further research is mandatory.</p>
Temporal Counterfactual Treatment Outcome Estimation Dataset
<p>Temporal Counterfactual Treatment Outcome Estimation Dataset</p>
Master Protocol to Study Treatment Patterns, Medication Adherence, Health and Economic Outcomes and Unmet Needs in RCC
ClinicalTrials.gov study NCT04375150. IPD Sharing: NO. Countries: 1. Publications: 0.
Root Canal Treatment Outcome in Patients Under Bisphosphonate Therapy
ClinicalTrials.gov study NCT04399720. IPD Sharing: NO. Countries: 0. Publications: 2.
Study to Evaluate Chronic Myeloid Leukemia Treatment Landscape and Real-life Treatment Outcomes in Hungary: Analysis of National Health Insurance Fund Database
ClinicalTrials.gov study NCT05286528. IPD Sharing: NO. Countries: 1. Publications: 0.
Shoulder Functional Outcomes of Patients With Proximal Humerus Fractures: Comparison of Two Different Treatment Protocol
ClinicalTrials.gov study NCT02467803. IPD Sharing: Not stated. Countries: 0. Publications: 1.
miRNAs, Suicide, and Ketamine - Plasma Exosomal microRNAs as Novel Biomarkers for Suicidality and Treatment Outcome
ClinicalTrials.gov study NCT02418195. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Effect of Reflexology Treatments on IVF Outcome
ClinicalTrials.gov study NCT02418364. IPD Sharing: Not stated. Countries: 0. Publications: 9.
A Prospective Study to Observe & Describe Clinical Outcomes of Alglucosidase Alfa Treatment in Patients ≤6 Months of Age With Infantile-onset Pompe Disease (IOPD)
ClinicalTrials.gov study NCT04848779. IPD Sharing: YES. Countries: 9. Publications: 0.
Observational Data Collection of Surgical Outcomes in the Treatment of Vaginal Prolapse With AMS Products
ClinicalTrials.gov study NCT00388947. IPD Sharing: NO. Countries: 1. Publications: 0.
IVF Outcome Following Treatment With Ulipristal Acetate for Myomatous Uterus After at Least One IVF Failure
ClinicalTrials.gov study NCT02601196. IPD Sharing: Not stated. Countries: 0. Publications: 10.
Sphenopalatine Ganglion Pulsed Radiofrequency Treatment Outcomes
ClinicalTrials.gov study NCT07370142. IPD Sharing: NO. Countries: 1. Publications: 0.
Medical Thoracoscopy in Treatment Outcomes of Empyema Management
ClinicalTrials.gov study NCT06132997. IPD Sharing: Not stated. Countries: 0. Publications: 2.
Treatment Outcome in Early Diffuse Cutaneous Systemic Sclerosis
ClinicalTrials.gov study NCT02339441. IPD Sharing: Not stated. Countries: 0. Publications: 2.
Impact of Antibiotic Treatment Following Implantation of Cardiac Electronic Device on Patient's Outcome
ClinicalTrials.gov study NCT03148444. IPD Sharing: UNDECIDED. Countries: 0. Publications: 8.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.